Midgard Science

abc biopply

Allschwil, Switzerland biopply.com

From their website, Nov 2026

Work here? Claim this listing

About

abc biopply AG provides preclinical CRO services and assay licensing based on proprietary 3D CoSeedis humanized multi-organoid in-chip technology. It works with biotech and pharma clients on drug efficacy, safety, toxicity, resistance, biomarker development, and custom disease-model design from its sites in Allschwil, Basel and Solothurn, Switzerland.

Services

  • Preclinical CRO Services

    Validated preclinical services for drug efficacy, safety, toxicity, resistance, and biomarker development on clinically relevant multi-organoid disease models.

  • Service Packages

    Bundled assay sets for drug development questions such as efficacy, resistance, toxicity, safety, target validation, marker studies, omics, and study planning.

  • Assays

    Highly standardized and validated 3D CoSeedis in-chip assays for individual preclinical readouts and project-specific study needs.

  • Licenses

    In-licensing options for the company's assays, protocols, disease models, and technology for in-house use.

  • Custom-tailored model development

    Design and development of custom disease models, including characterization and biomarker discovery.

  • Integrated preclinical services

    Preclinical services that combine in vitro to in vivo work synchronized with humanized mouse models through partner laboratories.

  • Target validation package

    Package for target localization, binding, activation, tissue penetration, and cytotoxicity studies during drug development and optimization.

  • Rapid Drug Efficacy Check

    Package for rapid prediction of clinically relevant drug efficacy and dosage using 3D CoSeedis tumor models and dose-response readouts.

  • Drug Safety Package

    Package covering IC50 determinations and off-target toxicity studies.

  • Drug Resistance Check

    Package covering IC50 determinations and long-term efficacy studies.

  • Personalized Efficacy Package

    Package for efficacy testing on PDCs with IC50 and dose-response studies.

  • Personalized Toxicity Target and off-Target Package

    Package for IC50, dose-response, and off-target toxicity studies on PDCs.

  • Pathway Analysis Package

    Package for IC50 determination and pathway dissection studies.

  • Drug Response Package

    Package for IC50 determination, dose-response, and clonal response studies.

  • Cell Viability Package

    Package for IC50 determination, dose-response, and cell survival studies.

  • Organoid service packages

    Bundles validated assay modules for drug efficacy, resistance, relapse, toxicity, safety, marker studies, tissue penetration, and omics.

  • Licensing of assays and protocols

    Provides in-licensing options for proprietary assays, protocols, disease models, and technology for in-house use.

  • Custom disease model development

    Designs and custom-tailors disease models and supports biomarker discovery for client projects.

  • Integrated preclinical study support

    Supports preclinical study design and planning and connects in vitro work with humanized mouse models through partners.

Turnaround
10 weeks to result · 12 weeks to result
What to send
Choose a 3D CoSeedis tumor model · One drug - one target

Capabilities

Assays and studies
Toxicology · In vivo · Rodent models · Apoptosis · Co-culture · Cytotoxicity · Dose response · Drug efficacy · Tumor relapse · Histology · Live cell detection · Antibody penetration
11 moreLate stage cancer relapse · Colony forming · Off-target cytotoxicity · Drug penetration · Marker studies · Omics · IC50 determination · Drug efficacy assay · Drug safety assay · Toxicology assay · Drug resistance assay
Scale and capacity
Up to 1000 replicates
Therapeutic areas
Oncology · Neurology · Hepatology · Nephrology · Obesity · Cartilage · Renal

Instruments and platforms

  • 3D CoSeedis in chip technology
  • 3D CoSeedis™ chips

Modalities and species

Modalities
Organoid models · Multi-organoid disease models · Humanized mouse models · Patient-derived cells · Organoid · Humanized multi-organoid disease models
Species and models
3D CoSeedis tumor models · Oncology · Neurology · Hepatic · Renal · Cartilage · Obesity · PDCs · Humanized mouse models · Patient tissues · Healthy tissues · Diseased tissues

Industries served

  • Biotech
  • Pharma

Company

Type
CRO
Founded
2018

Locations

Address
Hegenheimermattweg 167A, 4123 Allschwil, Switzerland
Sites
Allschwil, Basel, Switzerland · Solothurn, Switzerland
Serves
Switzerland, EU, Canada, international, CH

Similar labs

Work here? Claim this listing